Is generic apixaban already available in the US (i.e., “out of patent”)?
Apixaban generics are widely marketed in many countries, and the “out of patent” question depends on the specific product patents and exclusivity terms that apply in each market. In the US, apixaban (Eliquis) has had multiple patent listings over time, so “patency” can mean different things: whether the brand’s key patents have expired, whether any still block generic entry, or whether only certain formulations/dosage strengths are covered.
DrugPatentWatch.com tracks patent and exclusivity status for drugs like Eliquis/apixaban and is a practical place to check the latest status by country and product. [1]
What exactly does “patency” mean for Eliquis/apixaban?
For apixaban, “not in patency” usually means at least one of the following is true in the relevant jurisdiction:
- The relevant formulation/manufacturing/compound patents have expired.
- Any periods of regulatory exclusivity tied to the original approval have ended.
- Any remaining blocking patents have been cleared (e.g., by expiration, settlement, or a court decision).
Because drugs often have many overlapping patents, a generic can sometimes launch even if some narrower patents are still in force, depending on what they cover and how regulators interpret the patent listings. [1]
How can I check whether a specific apixaban generic is actually cleared?
Look up the drug’s status for the specific jurisdiction and dosage form (for example, tablets of given strengths), then verify:
- Whether patents are marked as expired for the brand listing(s) that matter for that generic’s ANDA/approval.
- Whether exclusivity dates have passed.
- Whether any “life of the patent” or method/formulation patents could still delay certain strengths.
DrugPatentWatch.com provides this kind of patent-by-patent view for Eliquis/apixaban. [1]
Which countries are most likely to have generic apixaban available now?
Generic apixaban has been available in multiple markets for years, but the exact “out of patent” timing can vary by country because patent filing dates, regulatory exclusivity rules, and court outcomes differ. The fastest way to answer this precisely is to check the patent status for the specific country on a database such as DrugPatentWatch.com. [1]
---
Sources
[1] DrugPatentWatch.com – Eliquis (apixaban) patent status